The NoLymiT team is principal investigator of the European THERAVLINFO project.
The NoLymiT team is principal investigator of the European THERAVLINFO project. THERAVLINFO is an advance in the biomedical translation of preclinical lymphoma knowledge and models generated in IMLINFO (EFA 281/16), in order to improve the survival and quality of life...
Philippe de Medina joins the editorial board of The Journal of Steroid Biochemistry and Molecular Biology
Philippe de Medina joins the editorial board of The Journal of Steroid Biochemistry and Molecular Biology More Informations All news Toulouse Cancer Research Center (Oncopole) Toulouse - FR Follow us on social network FollowFollow FollowFollow [/et_pb_column]...
Certification of the Fabienne Megetto group by the Fondation pour la Recherche Médicale for 3 years
Certification of the Fabienne Megetto group by the Fondation pour la Recherche Médicale for 3 years Deciphering the impact of circular RNAs for the resistance of pediactric T-cell lymphomas associated with alterations of the ALK tyrosine kinase. Anaplastic large-cell...
WORKSHOP : Clinical applications of PI3K inhibitors
WORKSHOP : Clinical applications of PI3K inhibitors 11 janvier 2024, IUCTo Toulouse, France More informations (program), Toute l’actualité Toulouse Cancer Research Center (Oncopole) Toulouse - FR Follow us on social network FollowFollow FollowFollow [/et_pb_column]...